<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>snri Archives - Gateway Psychiatric</title>
	<atom:link href="https://www.gatewaypsychiatric.com/tag/snri/feed/" rel="self" type="application/rss+xml" />
	<link></link>
	<description>Excellent Psychiatric Care</description>
	<lastBuildDate>Tue, 06 Jul 2021 23:02:49 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=6.9.1</generator>

<image>
	<url>https://i0.wp.com/www.gatewaypsychiatric.com/wp-content/uploads/2013/06/favicon2.png?fit=32%2C32&#038;ssl=1</url>
	<title>snri Archives - Gateway Psychiatric</title>
	<link></link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">70562394</site>	<item>
		<title>Antidepressant Response Linked to Norepinephrine Transporter Genotype</title>
		<link>https://www.gatewaypsychiatric.com/antidepressant-response-linked-norepinephrine-transporter-genotype/</link>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Sun, 15 Jan 2017 03:06:41 +0000</pubDate>
				<category><![CDATA[Best Practices]]></category>
		<category><![CDATA[Major Depression]]></category>
		<category><![CDATA[Testing]]></category>
		<category><![CDATA[Treatments of Depression]]></category>
		<category><![CDATA[antidepressant]]></category>
		<category><![CDATA[genetic testing]]></category>
		<category><![CDATA[major depression]]></category>
		<category><![CDATA[norepinephrine transporter]]></category>
		<category><![CDATA[snri]]></category>
		<category><![CDATA[treatment response]]></category>
		<category><![CDATA[venlafaxine]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=12213</guid>

					<description><![CDATA[<p>A large study of patients treated with venlafaxine found that antidepressant response was linked to the norepinephrine transporter (NET) genotype. The study looked at response in a sample of 350 individuals over the age of 60 with severe depression (MADRS greater than or equal to 15) who were treated with venlafaxine up to a dose of 300 mg a day. ... </p>
<div><a href="https://www.gatewaypsychiatric.com/antidepressant-response-linked-norepinephrine-transporter-genotype/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/antidepressant-response-linked-norepinephrine-transporter-genotype/">Antidepressant Response Linked to Norepinephrine Transporter Genotype</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">12213</post-id>	</item>
		<item>
		<title>Norepinephrine dopamine and depression</title>
		<link>https://www.gatewaypsychiatric.com/norepinephrine-dopamine-and-depression/</link>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Sun, 21 Feb 2016 19:11:28 +0000</pubDate>
				<category><![CDATA[Basic Science]]></category>
		<category><![CDATA[Major Depression]]></category>
		<category><![CDATA[Psychobiology]]></category>
		<category><![CDATA[Treatments of Depression]]></category>
		<category><![CDATA[defeat]]></category>
		<category><![CDATA[depression]]></category>
		<category><![CDATA[dopamine]]></category>
		<category><![CDATA[locus coeruleus]]></category>
		<category><![CDATA[norepinephrine]]></category>
		<category><![CDATA[resilience]]></category>
		<category><![CDATA[snri]]></category>
		<category><![CDATA[stress]]></category>
		<category><![CDATA[treatments of depression]]></category>
		<category><![CDATA[ventral tegmental area]]></category>
		<category><![CDATA[vulnerability]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=10088</guid>

					<description><![CDATA[<p>In an elegant set of studies&#160;published in February 2016 in Nature Neuroscience&#160;the team of Bruno Giros, a researcher at the Douglas Mental Health University Institute and Professor of Psychiatry at McGill University, reports the first-ever connection between noradrenergic neurons and vulnerability to depression. The study involved research using probably the most well developed animal model for depression &#8211; chronic or ... </p>
<div><a href="https://www.gatewaypsychiatric.com/norepinephrine-dopamine-and-depression/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/norepinephrine-dopamine-and-depression/">Norepinephrine dopamine and depression</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">10088</post-id>	</item>
		<item>
		<title>Functional Brain Imaging and Antidepressant Response</title>
		<link>https://www.gatewaypsychiatric.com/functional-brain-imaging-and-antidepressant-response/</link>
		
		<dc:creator><![CDATA[Peter Forster]]></dc:creator>
		<pubDate>Wed, 10 Feb 2016 04:33:45 +0000</pubDate>
				<category><![CDATA[Basic Science]]></category>
		<category><![CDATA[Testing]]></category>
		<category><![CDATA[Treatments of Depression]]></category>
		<category><![CDATA[antidepressant]]></category>
		<category><![CDATA[escitalopram]]></category>
		<category><![CDATA[functional brain imaging]]></category>
		<category><![CDATA[major depression]]></category>
		<category><![CDATA[outcomes]]></category>
		<category><![CDATA[prediction]]></category>
		<category><![CDATA[resting state fMRI]]></category>
		<category><![CDATA[sertraline]]></category>
		<category><![CDATA[snri]]></category>
		<category><![CDATA[ssri]]></category>
		<category><![CDATA[treatment response]]></category>
		<category><![CDATA[venlafaxine]]></category>
		<guid isPermaLink="false">https://www.gatewaypsychiatric.com/?p=10053</guid>

					<description><![CDATA[<p>One of the most exciting initiatives currently in the important area of  the treatment of depression is the International Study to Predict Optimized Treatment in Depression (iSPOT-D). This large multi-center initiative is based on a private industry and academic partnership that is designed to both identify best practices in the treatment of depression and also commercialize them. The most recent publication from this ... </p>
<div><a href="https://www.gatewaypsychiatric.com/functional-brain-imaging-and-antidepressant-response/" class="more-link">Read More</a></div>
<p>The post <a href="https://www.gatewaypsychiatric.com/functional-brain-imaging-and-antidepressant-response/">Functional Brain Imaging and Antidepressant Response</a> appeared first on <a href="https://www.gatewaypsychiatric.com">Gateway Psychiatric</a>.</p>
]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">10053</post-id>	</item>
	</channel>
</rss>
